Skip to main content

Dr. Kate Sasser

Equibles does not estimate personal net worth.

Get an email with a short summary when Shattuck Labs, Inc. publishes a filing, an earnings call transcript or a press release.

Get STTK alerts

About Dr. Kate Sasser

Dr. Kate Sasser is recorded as Board Member at Shattuck Labs, Inc. (STTK) since March 1, 2024. Shattuck Labs, Inc. reported in an 8-K filed March 4, 2024 that Dr. Kate Sasser was appointed Class II director, effective March 1, 2024. Shattuck Labs, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Shattuck Labs, Inc. includes Taylor Schreiber (CEO and Board Member), George Golumbeski (Chairman), Andrew Neill (CFO) and 7 others.

“On March 1, 2024, the Board of Directors (the "Board") of Shattuck Labs, Inc. (the "Company") expanded its size and appointed: (i) Dr. Kate Sasser as a Class II director to serve until the Company's 2025 Annual Meeting of Stockholders and until her successor is duly elected and qualified and (ii) Dr. Clay Siegall as a Class III director to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified, effective immediately.”
Shattuck Labs, Inc. Form 8-K, filed March 4, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Shattuck Labs, Inc.

Recent activity